Janet A Hindler
Overview
Explore the profile of Janet A Hindler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
1901
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Humphries R, Ambler J, Mitchell S, Castanheira M, Dingle T, Hindler J, et al.
J Clin Microbiol
. 2023 Sep;
61(10):e0073923.
PMID: 37732793
No abstract available.
2.
Humphries R, Miller L, Zimmer B, Matuschek E, Hindler J
J Clin Microbiol
. 2023 Mar;
61(6):e0188622.
PMID: 36971571
Antibacterial susceptibility testing (AST) is performed to guide therapy, perform resistance surveillance studies, and support development of new antibacterial agents. For 5 decades, broth microdilution (BMD) has served as the...
3.
Simner P, Hindler J, Bhowmick T, Das S, Johnson J, Lubers B, et al.
J Clin Microbiol
. 2022 Aug;
60(10):e0221021.
PMID: 35916520
A vast amount of antimicrobial susceptibility test (AST) data is generated from routine testing in diagnostic laboratories for the primary purpose of guiding clinicians in antimicrobial therapy decisions for their...
4.
Humphries R, Bobenchik A, Hindler J, Schuetz A
J Clin Microbiol
. 2021 Sep;
59(12):e0021321.
PMID: 34550809
The Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing (AST) develops and publishes standards and guidelines for AST methods and results interpretation in an annual update to...
5.
Whitley V, Kircher S, Gill T, Hindler J, ORourke S, Cooper C, et al.
J Clin Microbiol
. 2020 Mar;
58(5).
PMID: 32132195
Limited treatment options contribute to high morbidity/mortality rates with carbapenem-resistant, Gram-negative bacterial infections. New approaches for carbapenemase-producing organism (CPO) detection may help inform clinician decision-making on patient treatment and infection...
6.
Humphries R, Abbott A, Hindler J
J Clin Microbiol
. 2019 Apr;
57(6).
PMID: 30971460
The Clinical and Laboratory Standards Institute (CLSI) has revised several breakpoints since 2010 for bacteria that grow aerobically. In 2019, these revisions include changes to the ciprofloxacin and levofloxacin breakpoints...
7.
Humphries R, Hindler J, Shaffer K, Campeau S
J Clin Microbiol
. 2018 Dec;
57(3).
PMID: 30567744
In 2019, the Clinical and Laboratory Standards Institute (CLSI) published revisions to the ciprofloxacin and levofloxacin breakpoints. We evaluated the performance of disk diffusion and Etest compared to that of...
8.
Simner P, Bergman Y, Trejo M, Roberts A, Marayan R, Tekle T, et al.
J Clin Microbiol
. 2018 Oct;
57(2).
PMID: 30282791
Limited methods for colistin MIC determination are available to clinical microbiology laboratories. The purpose of this study was to evaluate the accuracy of the colistin broth disk elution (CBDE) test...
9.
Humphries R, Ferraro M, Hindler J
J Clin Microbiol
. 2018 Feb;
56(5).
PMID: 29436415
Antimicrobial resistance is the most pressing medical challenge of the past decade. At the front line are clinical laboratories, which are responsible for accurately reporting antimicrobial susceptibility test (AST) results...
10.
Humphries R, Ambler J, Mitchell S, Castanheira M, Dingle T, Hindler J, et al.
J Clin Microbiol
. 2018 Jan;
56(4).
PMID: 29367292
Effective evaluations of antimicrobial susceptibility tests (ASTs) require robust study design. The Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing has recognized that many published studies reporting...